WIN Symposium shared on LinkedIn:
“Program spotlight: WIN International Molecular Tumor Board
At WIN Symposium 2026, the WIN International Molecular Tumor Board will bring together multidisciplinary international experts for live case discussions from WIN Consortium institutions, with audience participation encouraged.
The tumor board will be chaired by Dr. Razelle Kurzrock, WIN Consortium, Chevilly-Larue, France, and Medical College of Wisconsin, Milwaukee, WI, USA.
Co-chairs include Dr. Wafik El-Deiry, WIN Consortium, Chevilly-Larue, France, and Brown University Health, Providence, RI, USA; and Dr. Sewanti A. Limaye, WIN Consortium, Chevilly-Larue, France, and Sir H.N. Reliance Foundation Hospital and Research Centre, Mumbai, India.
Panelists include Dr. Giuseppe Curigliano, Dr. Vivek Subbiah, Dr. Giselle L. Saulnier Sholler, and Dr. Bicky Thapa.
Poster abstract submission closes August 21, 2026.
Register now and submit your abstract by the deadline.
WIN Symposium 2026, endorsed by ASCO, will take place October 2-3, 2026 in Providence, Rhode Island, USA.
ASCO and American Society of Clinical Oncology (ASCO are registered trademarks of the American Society of Clinical Oncology, Inc. Used with permission. This is not an ASCO sponsored event.
Other articles from WIN Symposium on OncoDaily.
